Combined hormonal contraception and the risk of venous thromboembolism: a guideline

All combined hormonal contraceptives increase the risk of venous thromboembolism. In the patient in whom combined hormonal contraception is appropriate, it is reasonable to use any currently available preparation.

Like Comment

Volume 107, Issue 1, Pages 43-51

Authors:

Practice Committee of the American Society for Reproductive Medicine

Abstract:

While venous thromboembolism (VTE) is rare in young women of reproductive age, combined oral contraceptives increase the risk of VTE. In the patient in whom combined hormonal contraception is appropriate, it is reasonable to use any currently available preparation.


Read the full text here.

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.